-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on IDEXX Laboratories, Raises Price Target to $580

Benzinga·06/11/2025 18:13:52
Listen to the news
Leerink Partners analyst Daniel Clark maintains IDEXX Laboratories (NASDAQ:IDXX) with a Outperform and raises the price target from $515 to $580.